Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
Public ClinicalTrials.gov record NCT00060996. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Placebo-Controlled, 12-Week Multicenter Study of the Safety and Efficacy of Continuous or Daily Administration of Remodulin® (Treprostinil Sodium) Injection in Patients With CLI With No Planned Revascularization Procedures
Study identification
- NCT ID
- NCT00060996
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- United Therapeutics
- Industry
- Enrollment
- 30 participants
Conditions and interventions
Interventions
- Remodulin® (treprostinil sodium) Injection Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2003
- Primary completion
- Aug 31, 2004
- Completion
- Aug 31, 2004
- Last update posted
- Mar 6, 2013
2003 – 2004
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Florida College of Medicine | Tampa | Florida | 33606 | — |
| University of Massachusetts Memorial Health | Worcester | Massachusetts | 01655 | — |
| Minneapolis Heart Institute | Minneapolis | Minnesota | 55407-1139 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239 | — |
| Presbyterian Medical Center, Philadelphia Heart Institute | Philadelphia | Pennsylvania | 19104 | — |
| South Carolina Heart Center | Columbia | South Carolina | 29204 | — |
| The Methodist Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00060996, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00060996 live on ClinicalTrials.gov.